Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway

Chen,Xingwang; Yao,Zhijun; Peng,Xian; Wu,Long; Wu,Huachu; Ou,Yuantong; Lai,Jianbo

doi:10.3892/mmr.2020.11637

Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway

Authors:
- Xingwang Chen
- Zhijun Yao
- Xian Peng
- Long Wu
- Huachu Wu
- Yuantong Ou
- Jianbo Lai
View Affiliations

Affiliations: Department of Intensive Care Unit, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China
Published online on: October 26, 2020 https://doi.org/10.3892/mmr.2020.11637
Pages: 5135-5144
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Eupatorium perfoliatum L. (E. perfoliatium) has been used traditionally for treating fever, malaria and inflammation‑associated diseases. Eupafolin, the extract of E. perfoliatium, was also reported to suppress inflammation. The present study aimed to investigate the protective effects of eupafolin on cerebral ischemia/reperfusion (I/R) injury in rats and its possible underlying mechanisms. Cerebral I/R injury was induced in rats by middle cerebral artery occlusion (MCAO) for 1.5 h, followed by reperfusion. The rats were randomly assigned into six groups: Control, model, 10 mg/kg eupafolin, 20 mg/kg eupafolin, 50 mg/kg eupafolin and 20 mg/kg nimodipine. Eupafolin and nimodipine were intragastrically administrated to the rats 1 week before MCAO induction. Following reperfusion for 24 h, the neurological deficit was scored, and brain samples were harvested for evaluating encephaledema, infarct volume, oxidative stress, apoptosis, inflammation and the expression of TLR4/NF‑κB signaling. The results revealed that eupafolin decreased the neurological score, relieved encephaledema and decreased infarct volume. Eupafolin also attenuated oxidative stress, neuronal apoptosis and inflammation, with decreases in lactate dehydrogenase, malondialdehyde, TUNEL‑positive cells, Bax and caspase‑3, along with TNF‑α, IL‑1β and IL‑6, but increases in superoxide dismutase and Bcl‑2 levels. Furthermore, eupafolin may decrease the expression of TLR4 downstream proteins and proteins involved in the NF‑κB pathway. Treatment with TLR4 agonist‑LPS significantly blunted the protective effect of eupafolin on encephaledema and cerebral infarct. Meanwhile, 20 mg/kg eupafolin showed nearly equivalent effects to the positive‑control drug nimodipine. In conclusion, eupafolin protected against cerebral I/R injury in rats and the underlying mechanism may be associated with the suppression of apoptosis and inflammation via inhibiting the TLR4/ NF‑κB signaling pathway.

View Figures

View References

1	Bustamante A and Montaner J: Author response: Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke. Neurology. 91:8992018. View Article : Google Scholar : PubMed/NCBI
2	Kahl A, Blanco I, Jackman K, Baskar J, Mohan HM, Rodney-Sandy R, Zhang S, Iadecola C and Hochrainer K: Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci Rep. 8:27012018. View Article : Google Scholar : PubMed/NCBI
3	Huang J, Wang T, Yu D, Fang X, Fan H and Liu Q, Yi G, Yi X and Liu Q: l-homocarnosine attenuates inflammation in cerebral ischemia-reperfusion injury through inhibition of nod-like receptor protein 3 inflammasome. Int J Biol Macromol. 118:357–364. 2018. View Article : Google Scholar : PubMed/NCBI
4	Zhang H, Park JH, Maharjan S, Park JA, Choi KS, Park H, Jeong Y, Ahn JH, Kim IH, Lee JC, et al: Sac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation. J Neuroinflammation. 14:1222017. View Article : Google Scholar : PubMed/NCBI
5	Ya BL, Liu Q, Li HF, Cheng HJ, Yu T, Chen L, Wang Y, Yuan LL, Li WJ, Liu WY and Bai B: Uric acid protects against focal cerebral ischemia/reperfusion-induced oxidative stress via activating Nrf2 and regulating neurotrophic factor expression. Oxid Med Cell Longev. 2018:60691502018. View Article : Google Scholar : PubMed/NCBI
6	Li X, Cheng S, Hu H, Zhang X, Xu J, Wang R and Zhang P: Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress. Biochem Biophys Res Commun. 521:569–576. 2020. View Article : Google Scholar : PubMed/NCBI
7	Cui Y, Wang JQ, Shi XH, Wang YY, Liu HY, Li Z, Dong Y, Mang J and Xu ZX: Nodal mitigates cerebral ischemia-reperfusion injury via inhibiting oxidative stress and inflammation. Eur Rev Med Pharmacol Sci. 23:5923–5933. 2019.PubMed/NCBI
8	Lee CW, Lin ZC, Hsu LF, Fang JY, Chiang YC, Tsai MH, Lee MH, Li SY, Hu SC, Lee IT and Yen FL: Eupafolin ameliorates COX-2 expression and PGE2 production in particulate pollutants-exposed human keratinocytes through ROS/MAPKs pathways. J Ethnopharmacol. 189:300–309. 2016. View Article : Google Scholar : PubMed/NCBI
9	Maas M, Deters AM and Hensel A: Anti-inflammatory activity of Eupatorium perfoliatum L. Extracts, eupafolin, and dimeric guaianolide via iNOS inhibitory activity and modulation of inflammation-related cytokines and chemokines. J Ethnopharmacol. 137:371–381. 2011. View Article : Google Scholar : PubMed/NCBI
10	Zhang H, Chen MK, Li K, Hu C, Lu MH and Situ J: Eupafolin nanoparticle improves acute renal injury induced by LPS through inhibiting ROS and inflammation. Biomed Pharmacother. 85:704–711. 2017. View Article : Google Scholar : PubMed/NCBI
11	Gao Y, Zhang Y and Fan Y: Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway. Iran J Basic Med Sci. 22:1340–1346. 2019.PubMed/NCBI
12	Sung HC, Liang CJ, Lee CW, Yen FL, Hsiao CY, Wang SH, Jiang-Shieh YF, Tsai JS and Chen YL: The protective effect of eupafolin against TNF-α-induced lung inflammation via the reduction of intercellular cell adhesion molecule-1 expression. J Ethnopharmacol. 170:136–147. 2015. View Article : Google Scholar : PubMed/NCBI
13	Fan X, Tao J, Cai Z, Fredimoses M, Wu J, Jiang Z, Zhang K and Li S: Eupafolin suppresses esophagus cancer growth by targeting T-LAK cell-originated protein kinase. Front Pharmacol. 10:12482019. View Article : Google Scholar : PubMed/NCBI
14	Jiang H, Wu D, Xu D, Yu H, Zhao Z, Ma D and Jin J: Eupafolin exhibits potent anti-angiogenic and antitumor activity in hepatocellular carcinoma. Int J Biol Sci. 13:701–711. 2017. View Article : Google Scholar : PubMed/NCBI
15	Han MA, Min KJ, Woo SM, Seo BR and Kwon TK: Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells. Oncotarget. 7:65707–65720. 2016. View Article : Google Scholar : PubMed/NCBI
16	Liu K, Park C, Chen H, Hwang J, Thimmegowda NR, Bae EY, Lee KW, Kim HG, Liu H, Soung NK, et al: Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling. Mol Carcinog. 54:751–760. 2015. View Article : Google Scholar : PubMed/NCBI
17	Lester SN and Li K: Toll-like receptors in antiviral innate immunity. J Mol Biol. 426:1246–1264. 2014. View Article : Google Scholar : PubMed/NCBI
18	Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL, Kao RL, Browder IW, Schweitzer JB, Kalbfleisch JH and Li C: Activation of toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol. 190:101–111. 2007. View Article : Google Scholar : PubMed/NCBI
19	van Delft MA, Huitema LF and Tas SW: The contribution of NF-κB signalling to immune regulation and tolerance. Eur J Clin Invest. 45:529–539. 2015. View Article : Google Scholar : PubMed/NCBI
20	Liang W, Lin C, Yuan L, Chen L, Guo P, Li P, Wang W and Zhang X: Preactivation of Notch1 in remote ischemic preconditioning reduces cerebral ischemia-reperfusion injury through crosstalk with the NF-κB pathway. J Neuroinflammation. 16:1812019. View Article : Google Scholar : PubMed/NCBI
21	Auvin S, Shin D, Mazarati A and Sankar R: Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia. 51 (Suppl 3):S34–S38. 2010. View Article : Google Scholar
22	Zhao R, Jiang J, Li H, Chen M, Liu R, Sun S, Ma D, Liang X and Wang S: Phosphatidylserine-microbubble targeting-activated microglia/macrophage in inflammation combined with ultrasound for breaking through the blood-brain barrier. J Neuroinflammation. 15:3342018. View Article : Google Scholar : PubMed/NCBI
23	Sommer CJ: Ischemic stroke: Experimental models and reality. Acta Neuropathol. 133:245–261. 2017. View Article : Google Scholar : PubMed/NCBI
24	Li P, Zhang Y and Liu H: The role of Wnt/β-catenin pathway in the protection process by dexmedetomidine against cerebral ischemia/reperfusion injury in rats. Life Sci. 236:1169212019. View Article : Google Scholar : PubMed/NCBI
25	Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL and Bartkowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI
26	Yang Z, Weian C, Susu H and Hanmin W: Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms. Eur J Pharmacol. 771:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
27	Gong L, Tang Y, An R, Lin M, Chen L and Du J: RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis. 8:e30802017. View Article : Google Scholar : PubMed/NCBI
28	Jing H, Liu L, Jia Y, Yao H and Ma F: Overexpression of the long non-coding RNA Oprm1 alleviates apoptosis from cerebral ischemia-reperfusion injury through the Oprm1/miR-155/GATA3 axis. Artif Cells Nanomed Biotechnol. 47:2431–2439. 2019. View Article : Google Scholar : PubMed/NCBI
29	Yamashita T and Abe K: Recent progress in therapeutic strategies for ischemic stroke. Cell Transplant. 25:893–898. 2016. View Article : Google Scholar : PubMed/NCBI
30	Hensel A, Maas M, Sendker J, Lechtenberg M, Petereit F, Deters A, Schmidt T and Stark T: Eupatorium perfoliatum L.: Phytochemistry, traditional use and current applications. J Ethnopharmacol. 138:641–651. 2011. View Article : Google Scholar : PubMed/NCBI
31	Sanz JM, Chiozzi P, Colaianna M, Zotti M, Ferrari D, Trabace L, Zuliani G and Di Virgilio F: Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia. Br J Pharmacol. 167:1702–1711. 2012. View Article : Google Scholar : PubMed/NCBI
32	Wang GH, Liu Y, Wu XB, Lu Y, Liu J, Qin YR, Li T and Duan HF: Neuroprotective effects of human umbilical cord-derived mesenchymal stromal cells combined with nimodipine against radiation-induced brain injury through inhibition of apoptosis. Cytotherapy. 18:53–64. 2016. View Article : Google Scholar : PubMed/NCBI
33	Yan B, Sun Y, Zeng J, Chen Y, Li C, Song P, Zhang L, Yang X, Wu Y and Ma P: Combined use of vitamin E and nimodipine ameliorates dibutyl phthalate-induced memory deficit and apoptosis in mice by inhibiting the ERK 1/2 pathway. Toxicol Appl Pharmacol. 368:1–17. 2019. View Article : Google Scholar : PubMed/NCBI
34	Ko HH, Chiang YC, Tsai MH, Liang CJ, Hsu LF, Li SY, Wang MC, Yen FL and Lee CW: Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways. J Ethnopharmacol. 151:386–393. 2014. View Article : Google Scholar : PubMed/NCBI
35	Chen CC, Lin MW, Liang CJ and Wang SH: The anti-inflammatory effects and mechanisms of eupafolin in lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. PLoS One. 11:e01586622016. View Article : Google Scholar : PubMed/NCBI
36	Luo SY, Li R, Le ZY, Li QL and Chen ZW: Anfibatide protects against rat cerebral ischemia/reperfusion injury via TLR4/JNK/caspase-3 pathway. Eur J Pharmacol. 807:127–137. 2017. View Article : Google Scholar : PubMed/NCBI
37	de Groen RAL, Schrader AMR, Kersten MJ, Pals ST and Vermaat JSP: MYD88 in the driver's seat of B-cell lymphomagenesis: From molecular mechanisms to clinical implications. Haematologica. 104:2337–2348. 2019. View Article : Google Scholar : PubMed/NCBI
38	Araya EI, Barroso AR, Turnes JM, Radulski DR, Jaganaught JA, Zampronio AR and Chichorro JG: Toll-like receptor 4 (TLR4) signaling in the trigeminal ganglion mediates facial mechanical and thermal hyperalgesia in rats. Physiol Behav. 226:1131272020. View Article : Google Scholar : PubMed/NCBI